Literature DB >> 8157984

A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood.

S Perticarari1, G Presani, E Banfi.   

Abstract

Phagocytes play an important role in host defence against microorganisms and different techniques are needed to evaluate their functional activities. Here we describe a rapid, simple and reliable one step procedure to measure the phagocytosis rate and oxidative burst activation of both polymorphonuclear leukocytes (PMN) and monocytes, by means of flow cytometry using only small quantities of whole blood. The two species of bacteria employed as test microorganisms, Staphylococcus aureus and Candida albicans showed a somewhat different behaviour. We found that the present method could be used as an alternative test in the diagnosis of chronic granulomatous disease (CGD). Moreover we were able to analyse, in a one step procedure, defective phagocyte functions in a group of paediatric patients suffering from recurrent microbial infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157984     DOI: 10.1016/0022-1759(94)90251-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

Review 1.  Chronic granulomatous disease.

Authors:  D Goldblatt; A J Thrasher
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Oxidant generation by single infected monocytes after short-term fluorescence labeling of a protozoan parasite.

Authors:  Haeok K Chang; Colin Thalhofer; Breck A Duerkop; Joanna S Mehling; Shilpi Verma; Kenneth J Gollob; Roque Almeida; Mary E Wilson
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

3.  Assessing immune function in adult bronchiectasis.

Authors:  P T King; P Hutchinson; P W Holmes; N J Freezer; V Bennett-Wood; R Robins-Browne; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

4.  Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria.

Authors:  J Baran; K Guzik; W Hryniewicz; M Ernst; H D Flad; J Pryjma
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Phagocytosis and oxidative-burst response of planktonic Staphylococcus epidermidis RP62A and its non-slime-producing variant in human neutrophils.

Authors:  M Heinzelmann; D O Herzig; B Swain; M A Mercer-Jones; T M Bergamini; H C Polk
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

6.  Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-γ on human neutrophils and monocytes.

Authors:  Victoria M Shpacovitch; Micha Feld; Dirk Holzinger; Makiko Kido; Morley D Hollenberg; Francesca Levi-Schaffer; Nathalie Vergnolle; Stephan Ludwig; Johannes Roth; Thomas Luger; Martin Steinhoff
Journal:  Immunology       Date:  2011-04-19       Impact factor: 7.397

7.  Effects of anticoagulants and temperature on expression of activation markers CD11b and HLA-DR on human leukocytes.

Authors:  S Shalekoff; L Page-Shipp; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects.

Authors:  Sujin Chanchamroen; Chidchamai Kewcharoenwong; Wattanachai Susaengrat; Manabu Ato; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

9.  Heparin binding protein (CAP37) is an opsonin for Staphylococcus aureus and increases phagocytosis in monocytes.

Authors:  M Heinzelmann; A Platz; H Flodgaard; F N Miller
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

10.  Chronic infantile neurological cutaneous articular syndrome: CD10 over-expression in neutrophils is a possible key to the pathogenesis of the disease.

Authors:  Valentina Leone; Gianni Presani; Sandra Perticarari; Alberto Tommasini; Sergio Crovella; Alessandro Lenhardt; Paolo Picco; Loredana Lepore
Journal:  Eur J Pediatr       Date:  2003-08-20       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.